These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 16288878)

  • 81. Synthesis, SAR and pharmacology of CP-293,019: a potent, selective dopamine D4 receptor antagonist.
    Sanner MA; Chappie TA; Dunaiskis AR; Fliri AF; Desai KA; Zorn SH; Jackson ER; Johnson CG; Morrone JM; Seymour PA; Majchrzak MJ; Faraci WS; Collins JL; Duignan DB; Prete Di CC; Lee JS; Trozzi A
    Bioorg Med Chem Lett; 1998 Apr; 8(7):725-30. PubMed ID: 9871530
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Structure-based development of caged dopamine D
    Gienger M; Hübner H; Löber S; König B; Gmeiner P
    Sci Rep; 2020 Jan; 10(1):829. PubMed ID: 31965029
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Analogues of Arylamide Phenylpiperazine Ligands To Investigate the Factors Influencing D3 Dopamine Receptor Bitropic Binding and Receptor Subtype Selectivity.
    Hayatshahi HS; Xu K; Griffin SA; Taylor M; Mach RH; Liu J; Luedtke RR
    ACS Chem Neurosci; 2018 Dec; 9(12):2972-2983. PubMed ID: 30010318
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Regulation of D2 and D3 receptors in transfected cells by agonists and antagonists.
    Burris KD; Fausing SM; Molinoff PB
    Adv Pharmacol; 1998; 42():443-6. PubMed ID: 9327934
    [No Abstract]   [Full Text] [Related]  

  • 85. N-(4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl, butenyl and butynyl)arylcarboxamides as novel dopamine D(3) receptor antagonists.
    Newman AH; Cao J; Bennett CJ; Robarge MJ; Freeman RA; Luedtke RR
    Bioorg Med Chem Lett; 2003 Jul; 13(13):2179-83. PubMed ID: 12798330
    [TBL] [Abstract][Full Text] [Related]  

  • 86. A pharmacophore model for dopamine D4 receptor antagonists.
    Boström J; Gundertofte K; Liljeforsa T
    J Comput Aided Mol Des; 2000 Nov; 14(8):769-86. PubMed ID: 11131969
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Discovery of potent dual ligands for dopamine D4 and σ1 receptors.
    Levoin N; Murthy AVR; Narendar V; Kumar NS; Aparna P; Bhavani AKD; Reddy CR; Mosset P; Grée R
    Bioorg Med Chem; 2022 Sep; 69():116851. PubMed ID: 35753263
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Distinctive binding properties of the negative allosteric modulator, [
    Fasciani I; Pietrantoni I; Rossi M; Mannoury la Cour C; Aloisi G; Marampon F; Scarselli M; Millan MJ; Maggio R
    Eur J Pharmacol; 2018 Jan; 819():181-189. PubMed ID: 29223348
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Investigation of the binding and functional properties of extended length D3 dopamine receptor-selective antagonists.
    Furman CA; Roof RA; Moritz AE; Miller BN; Doyle TB; Free RB; Banala AK; Paul NM; Kumar V; Sibley CD; Newman AH; Sibley DR
    Eur Neuropsychopharmacol; 2015 Sep; 25(9):1448-61. PubMed ID: 25583363
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Fluorescent Tools for the Imaging of Dopamine D
    Nagl M; Mönnich D; Rosier N; Schihada H; Sirbu A; Konar N; Reyes-Resina I; Navarro G; Franco R; Kolb P; Annibale P; Pockes S
    Chembiochem; 2024 Jan; 25(2):e202300659. PubMed ID: 37942961
    [TBL] [Abstract][Full Text] [Related]  

  • 91. N-(4-(4-(2,3-dichloro- or 2-methoxyphenyl)piperazin-1-yl)butyl)heterobiarylcarboxamides with functionalized linking chains as high affinity and enantioselective D3 receptor antagonists.
    Newman AH; Grundt P; Cyriac G; Deschamps JR; Taylor M; Kumar R; Ho D; Luedtke RR
    J Med Chem; 2009 Apr; 52(8):2559-70. PubMed ID: 19331412
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Discovery, optimization, and characterization of novel D2 dopamine receptor selective antagonists.
    Xiao J; Free RB; Barnaeva E; Conroy JL; Doyle T; Miller B; Bryant-Genevier M; Taylor MK; Hu X; Dulcey AE; Southall N; Ferrer M; Titus S; Zheng W; Sibley DR; Marugan JJ
    J Med Chem; 2014 Apr; 57(8):3450-63. PubMed ID: 24666157
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Synthesis of 2-(2,3-dimethoxyphenyl)-4-(aminomethyl)imidazole analogues and their binding affinities for dopamine D(2) and D(3) receptors.
    Huang Y; Luedtke RR; Freeman RA; Wu L; Mach RH
    Bioorg Med Chem; 2001 Dec; 9(12):3113-22. PubMed ID: 11711286
    [TBL] [Abstract][Full Text] [Related]  

  • 94. The discovery of potent and selective dopamine D4 receptor antagonists.
    Faraci WS; Zorn SH; Sanner MA; Fliri A
    Curr Opin Chem Biol; 1998 Aug; 2(4):535-40. PubMed ID: 9736928
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Binding of [3H]U-101958 to sigma1 receptor-like sites in human cerebellum and neuroblastoma cells.
    Helmeste DM; Shioiri T; Mitsuhashi M; Tang SW
    Eur J Pharmacol; 1999 Apr; 370(2):205-9. PubMed ID: 10323271
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Synthesis and structure-activity relationships of N-(1-benzylpiperidin-4-yl)arylacetamide analogues as potent sigma1 receptor ligands.
    Huang Y; Hammond PS; Wu L; Mach RH
    J Med Chem; 2001 Dec; 44(25):4404-15. PubMed ID: 11728186
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Analogues of the dopamine D2 receptor antagonist L741,626: Binding, function, and SAR.
    Grundt P; Husband SL; Luedtke RR; Taylor M; Newman AH
    Bioorg Med Chem Lett; 2007 Feb; 17(3):745-9. PubMed ID: 17095222
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Signalling via rat dopamine D2-receptors expressed in mouse fibroblasts is not influenced by compounds binding to the sigma sites of these cells.
    Sommermeyer H; Dompert WU; Glaser T
    Cell Signal; 1993 Nov; 5(6):747-52. PubMed ID: 8130078
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Dopamine D(3) receptor antagonists. 1. Synthesis and structure-activity relationships of 5,6-dimethoxy-N-alkyl- and N-alkylaryl-substituted 2-aminoindans.
    Haadsma-Svensson SR; Cleek KA; Dinh DM; Duncan JN; Haber CL; Huff RM; Lajiness ME; Nichols NF; Smith MW; Svensson KA; Zaya MJ; Carlsson A; Lin CH
    J Med Chem; 2001 Dec; 44(26):4716-32. PubMed ID: 11741489
    [TBL] [Abstract][Full Text] [Related]  

  • 100. 1-Phenyl-3-amino-1,2,3,4-tetrahydronaphthalenes and related derivatives as ligands for the neuromodulatory sigma 3 receptor: further structure-activity relationships.
    Wyrick SD; Booth RG; Myers AM; Owens CE; Bucholtz EC; Hooper PC; Kula NS; Baldessarini RJ; Mailman RB
    J Med Chem; 1995 Sep; 38(19):3857-64. PubMed ID: 7562917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.